Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps

    Perioperative management of ophthalmic patients taking antithrombotic therapy

    Methodological quality of the review: Low confidence

    Author: Lip GYH, Durrani OM, Roldan V, Lip PL, Marin F, Reuser TQ.

    Region: Details not provided

    Sector: Antithrombotic therapy, ophthalmic patients, cataract surgery and glaucoma surgery

    Sub-sector: Aspirin, warfarin

    Type of cataract: Age-related cataract

    Equity focus: None specified

    Review type: Effectiveness review

    Quantitative synthesis method: Narrative analysis

    Qualitative synthesis methods: Not applicable

    Background

    Increasing numbers of patients who undergo ophthalmic surgery (including cataract, glaucoma and vitreoretinal surgery) use anticoagulant and antiplatelet therapy such as warfarin and aspirin. Authors note that these drugs are routinely discontinued preoperatively because of the perceived risk of intra or post-operative severe bleeding. However, authors argue that this practice is not based on published evidence and that risks to the patient are not fully understood.

    Research objectives

    The aim of this review was to provide a semi-systematic review of the current published evidence on the perioperative management of anticoagulant and antiplatelet therapy. In particular, we will review the risk of significant bleeding in patients on anticoagulant and anti-platelet therapy and determine what types of ophthalmic procedures are safer than others.

    Main findings

    32 retrospective or prospective studies were included in this review. Based on the literature, authors concluded that:

    • Aspirin and warfarin should not be discontinued prior to the use of local anaesthetic;
    • In the presence of ‘vasculopathic risk factors’, aspirin should not be stopped before any type of ophthalmic surgery;
    • Cataract surgery can be safely carried out in patients taking aspirin or warfarin;
    • With the exception of vitreoretinal surgery (as no evidence found) warfarin should be continued in patients undergoing ophthalmic surgery as the risk of thrombophilia is higher than the risk of significant bleeding.

    Authors suggested that current evidence supports the continued use of aspirin and, with some exceptions, warfarin in the perioperative period. For most types of surgical procedures, the risks of interrupting anticoagulation outweigh its benefits but clinical needs may dictate the disruption of warfarin or aspirin.

    The retrospective and prospective studies included in the review were small and authors recommend that high-quality prospective randomized studies should be conducted to further define and influence the risk of thrombotic complications.

    Methodology

    Authors conducted a search of MEDLINE, EMBASE and the Database of Abstracts of reviews Of Effects (DARE) and Cochrane Controlled trials register and Cochrane systematic reviews for published data between 1970 and 2009. It was not clear if there were any language restrictions, and whether the screening and data extraction of articles were conducted independently by two reviewers.

    Authors conducted a narrative synthesis of the data. The review lists the studies included in the review, the interventions, results and strength of evidence. However, the study designs and quality assessment criteria of included studies were not reported. More detail around methods and outcomes and quality assessment used to conduct this review are provided as web-only supplementary material and not included in the review itself. Supplementary material was not found as of 4 July 2014.

    Applicability/external validity

    The review did not directly discuss the external validity of the findings from the review although did recognize that the review largely relied upon limited quality and quantity of evidence, therefore potentially limiting its applicability.

    Geographic focus

    The geographical location of the included studies was not reported by the review authors.

    Quality assessment

    Authors noted that details in regards to the methodology used to conduct this review were provided as a web-only supplementary material and not included in this review. Nevertheless, as this supplementary information was not available, quality assessment was based on the information provided in this review only. The authors conducted a narrative synthesis of included studies although, due to lack of information in the review itself on its methodology, it is not clear if meta-analysis of the data would have been possible or preferred.

    Authors made some strong recommendations and conclusions on the back of the review, however limitations to the review were reported, that is the quality of a number of the included studies was rated as ‘weaker evidence consisting of small non-comparative case series and case reports’. Therefore, low confidence was awarded to the conclusions about the effects of this study.

    Publication Details

    Lip GYH, Durrani OM, Roldan V, Lip PL, Marin F, Reuser TQ. Peri-operative management of ophthalmic patients taking antithrombotic therapy. The International Journal of Clinical Practice. 2011;65(3):361-71.

    Source

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.